A blood test for colon cancer could be on the horizon. But the …
About 1 in 5 African-American women with the disease have an …
Advertisement
Md. company to study cancer medicine feasibility
Idea uses gold nanoparticles to carry cancer meds
Updated: Thursday, 27 Dec 2012, 4:52 PM EST
Published : Thursday, 27 Dec 2012, 4:52 PM EST
ROCKVILLE, Md. (AP) - A Rockville company will study the feasibility of a new cancer medicine with the large pharmaceutical company AstraZeneca.
CytImmune Sciences Inc. and AstraZeneca made the announcement on Thursday.
The two companies will work together to see whether they can transmit cancer drugs on extremely small gold particles.
CytImmune works in developing nanomedicine, which uses tiny particles of gold to carry cancer therapies directly to the site of the disease. The company says gold nanoparticles have been used safely since the 1930s to treat patients with rheumatoid arthritis.
Dr. Lawrence Tamarkin, CytImmune's CEO, says the partnership aims to combine CytImmune's nanotechnology research with AstraZeneca's oncology compound to create a cancer therapy that may be widely applicable to solid tumors.
 | With WDTN.com's new commenting system you don't need to register. You can login with an existing Facebook, Yahoo!, Google, or Twitter account and more. |
Email This
Print This
View Story on a Single Page
Advertisement
Mugshot Gallery
The following people have recently been booked into Jail. They may not have been convicted of the crimes they are charged with and are innocent until proven guilty.
Advertisement
Advertisement